WallStreetZenWallStreetZen

NASDAQ: ERNA
Eterna Therapeutics Inc Stock

$2.24-0.02 (-0.88%)
Updated Mar 27, 2024
ERNA Price
$2.24
Fair Value Price
N/A
Market Cap
$12.12M
52 Week Low
$0.84
52 Week High
$3.75
P/E
-0.55x
P/B
5.43x
P/S
140.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$68.00k
Earnings
-$21.67M
Gross Margin
-247.1%
Operating Margin
-30,966.18%
Profit Margin
-31,888.2%
Debt to Equity
21
Operating Cash Flow
-$20M
Beta
0.87
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ERNA Overview

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ERNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ERNA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ERNA is good value based on its book value relative to its share price (5.43x), compared to the US Biotechnology industry average (6.2x)
P/B vs Industry Valuation
ERNA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ERNA due diligence checks available for Premium users.

Be the first to know about important ERNA news, forecast changes, insider trades & much more!

ERNA News

Valuation

ERNA fair value

Fair Value of ERNA stock based on Discounted Cash Flow (DCF)
Price
$2.24
Fair Value
$2.40
Undervalued by
6.48%
ERNA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ERNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.55x
Industry
14.3x
Market
44.45x

ERNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.43x
Industry
6.2x
ERNA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ERNA's financial health

Profit margin

Revenue
$17.0k
Net Income
-$6.2M
Profit Margin
-36,241.2%
ERNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ERNA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$49.1M
Liabilities
$46.9M
Debt to equity
21
ERNA's short-term assets ($9.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ERNA's long-term liabilities ($40.33M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ERNA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ERNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.7M
Investing
-$19.0k
Financing
$7.7M
ERNA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ERNA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ERNA$12.12M-0.88%-0.55x5.43x
PPBT$12.12M-1.77%N/A0.35x
ELAB$11.96M-1.43%N/A-72.96x
MBRX$12.34M+18.38%-0.37x0.47x
BNOX$11.90M-1.90%0.03x0.62x

Eterna Therapeutics Stock FAQ

What is Eterna Therapeutics's quote symbol?

(NASDAQ: ERNA) Eterna Therapeutics trades on the NASDAQ under the ticker symbol ERNA. Eterna Therapeutics stock quotes can also be displayed as NASDAQ: ERNA.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.

What is the 52 week high and low for Eterna Therapeutics (NASDAQ: ERNA)?

(NASDAQ: ERNA) Eterna Therapeutics's 52-week high was $3.75, and its 52-week low was $0.84. It is currently -40.27% from its 52-week high and 166.67% from its 52-week low.

How much is Eterna Therapeutics stock worth today?

(NASDAQ: ERNA) Eterna Therapeutics currently has 5,410,331 outstanding shares. With Eterna Therapeutics stock trading at $2.24 per share, the total value of Eterna Therapeutics stock (market capitalization) is $12.12M.

Eterna Therapeutics stock was originally listed at a price of $2,000.00 in Dec 31, 1997. If you had invested in Eterna Therapeutics stock at $2,000.00, your return over the last 26 years would have been -99.89%, for an annualized return of -23% (not including any dividends or dividend reinvestments).

How much is Eterna Therapeutics's stock price per share?

(NASDAQ: ERNA) Eterna Therapeutics stock price per share is $2.24 today (as of Mar 27, 2024).

What is Eterna Therapeutics's Market Cap?

(NASDAQ: ERNA) Eterna Therapeutics's market cap is $12.12M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eterna Therapeutics's market cap is calculated by multiplying ERNA's current stock price of $2.24 by ERNA's total outstanding shares of 5,410,331.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.